A possible explanation for the transient change in peripheral blood CD4 + T cell frequencies is that atezolizumab treatment leads to early mobilization of T helper cells into lymph node tissues (the site of the metastatic melanoma); however, this requires further investigation. Here, CD4 is linked to metastatic melanoma.